Fortrea Holdings (FTRE) Selling, General & Administrative (2022 - 2026)
Fortrea Holdings (FTRE) Selling, General & Administrative (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - | -10.08 Mn |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - | 2.17 Mn |
| 4 | BeOne Medicines | 469.79 Bn | 465.00 Bn | 1.35 Bn | 555.10 Mn |
| 5 | Vertex Pharmaceuticals | 122.95 Bn | 115.70 Bn | 2.59 Bn | 493.70 Mn |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.30 Bn | 3.31 Bn | 647.70 Mn |
| 7 | Belite Bio | 62.62 Bn | 62.62 Bn | - | 17.02 Mn |
| 8 | Argenx Se | 56.18 Bn | 50.99 Bn | 1.41 Bn | 1.13 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 101.25 Mn |
| 10 | Fortrea Holdings | 1.83 Bn | 1.68 Bn | 123.60 Mn | 100.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100.50 Mn |
| Dec 31, 2025 | 103.00 Mn |
| Sep 30, 2025 | 106.80 Mn |
| Jun 30, 2025 | 124.80 Mn |
| Mar 31, 2025 | 121.80 Mn |
| Dec 31, 2024 | 148.10 Mn |
| Sep 30, 2024 | 136.30 Mn |
| Jun 30, 2024 | 156.20 Mn |
| Mar 31, 2024 | 120.10 Mn |
| Dec 31, 2023 | 126.70 Mn |
| Sep 30, 2023 | 106.80 Mn |
| Jun 30, 2023 | 97.80 Mn |
| Mar 31, 2023 | 116.80 Mn |
| Dec 31, 2022 | 199.60 Mn |
| Sep 30, 2022 | 70.70 Mn |
| Jun 30, 2022 | 71.20 Mn |